Statement of Changes in Beneficial Ownership (4)
August 07 2020 - 7:37PM
Edgar (US Regulatory)
FORM 4
[ ]
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0287
Estimated average burden hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
THOMA BRAVO UGP, LLC |
2. Issuer Name and Ticker or Trading Symbol
Dynatrace, Inc.
[
DT
]
|
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director __X__ 10% Owner _____ Officer (give title below) _____ Other (specify below)
|
(Last)
(First)
(Middle)
C/O THOMA BRAVO, L.P., 150 NORTH RIVERSIDE PLAZA, SUITE 2800 |
3. Date of Earliest Transaction
(MM/DD/YYYY)
8/5/2020 |
(Street)
CHICAGO, IL 60606
(City)
(State)
(Zip)
|
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
___ Form filed by One Reporting Person
_
X
_ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
|
1.Title of Security (Instr. 3)
|
2. Trans. Date
|
2A. Deemed Execution Date, if any
|
3. Trans. Code (Instr. 8)
|
4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)
|
5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)
|
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)
|
7. Nature of Indirect Beneficial Ownership (Instr. 4)
|
Code
|
V
|
Amount
|
(A) or (D)
|
Price
|
Common Stock | 8/5/2020 | | S | | 21412966 | D | $40.90 (1) | 95078270 (2) | I (3) | See footnote (3) |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Trans. Date | 3A. Deemed Execution Date, if any | 4. Trans. Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) |
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
Explanation of Responses: |
(1) | Represents the offering price to the public of $41.10 per share, less the underwriters' discount of $0.20 per share. |
(2) | Consists of 10,429,397 shares held directly by Thoma Bravo Fund X, L.P. ("TB Fund X"), 2,281,350 shares held directly by Thoma Bravo Fund X-A, L.P. ("TB Fund X-A"), 49,124,660 shares held directly by Thoma Bravo Fund XI, L.P. ("TB Fund XI"), 24,671,613 shares held directly by Thoma Bravo Fund XI-A, L.P. ("TB Fund XI-A"), 1,083,735 shares held directly by Thoma Bravo Executive Fund XI, L.P. ("TB Exec Fund"), 894,849 shares held directly by Thoma Bravo Special Opportunities Fund I, L.P. ("TB SOF") and 6,592,666 shares held directly by Thoma Bravo Special Opportunities Fund I AIV, L.P. ("TB SOF AIV"). |
(3) | Thoma Bravo Partners X, L.P. ("TB Partners X") is the general partner of each of TB Fund X, TB Fund X-A, TB SOF and TB SOF AIV. Thoma Bravo Partners XI, L.P. ("TB Partners XI") is the general partner of each of TB Fund XI, TB Fund XI-A and TB Exec Fund. Thoma Bravo UGP, LLC is the ultimate managing member of TB Partners X and TB Partners XI. By virtue of the relationships described in this footnote, Thoma Bravo UGP, LLC may be deemed to exercise voting and dispositive power with respect to the shares held by TB Fund X, TB Fund X-A, TB SOF, TB SOF AIV, TB Fund XI, TB Fund XI-A and TB Exec Fund. Each of TB Partners X, TB Partners XI and Thoma Bravo UGP, LLC disclaims beneficial ownership of the shares owned by TB Fund X, TB Fund X-A, TB SOF, TB SOF AIV, TB Fund XI, TB Fund XI-A and TB Exec Fund except to the extent of its pecuniary interest therein. |
Reporting Owners
|
Reporting Owner Name / Address | Relationships |
Director | 10% Owner | Officer | Other |
THOMA BRAVO UGP, LLC C/O THOMA BRAVO, L.P. 150 NORTH RIVERSIDE PLAZA, SUITE 2800 CHICAGO, IL 60606 |
| X |
|
|
THOMA BRAVO PARTNERS X, L.P. C/O THOMA BRAVO, L.P. 150 NORTH RIVERSIDE PLAZA, SUITE 2800 CHICAGO, IL 60606 |
| X |
|
|
THOMA BRAVO PARTNERS XI, L.P. C/O THOMA BRAVO, L.P. 150 NORTH RIVERSIDE PLAZA, SUITE 2800 CHICAGO, IL 60606 |
| X |
|
|
THOMA BRAVO FUND X, L.P. C/O THOMA BRAVO, L.P. 150 NORTH RIVERSIDE PLAZA, SUITE 2800 CHICAGO, IL 60606 |
| X |
|
|
THOMA BRAVO FUND X-A, L.P. C/O THOMA BRAVO, L.P. 150 NORTH RIVERSIDE PLAZA, SUITE 2800 CHICAGO, IL 60606 |
| X |
|
|
THOMA BRAVO SPECIAL OPPORTUNITIES FUND I, L.P. C/O THOMA BRAVO, L.P. 150 NORTH RIVERSIDE PLAZA, SUITE 2800 CHICAGO, IL 60606 |
| X |
|
|
THOMA BRAVO SPECIAL OPPORTUNITIES FUND I AIV, L.P. C/O THOMA BRAVO, L.P. 150 NORTH RIVERSIDE PLAZA, SUITE 2800 CHICAGO, IL 60606 |
| X |
|
|
THOMA BRAVO FUND XI, L.P. C/O THOMA BRAVO, LLC 150 NORTH RIVERSIDE PLAZA, SUITE 2800 CHICAGO, IL 60606 |
| X |
|
|
THOMA BRAVO FUND XI-A, L.P. C/O THOMA BRAVO, L.P. 150 NORTH RIVERSIDE PLAZA, SUITE 2800 CHICAGO, IL 60606 |
| X |
|
|
THOMA BRAVO EXECUTIVE FUND XI, L.P. C/O THOMA BRAVO, L.P. 150 NORTH RIVERSIDE PLAZA, SUITE 2800 CHICAGO, IL 60606 |
| X |
|
|
Signatures
|
/s/ Seth Boro, Managing Partner of Thoma Bravo UGP, LLC | | 8/5/2020 |
**Signature of Reporting Person | Date |
/s/ Seth Boro, Managing Partner of Thoma Bravo Partners X, L.P. | | 8/5/2020 |
**Signature of Reporting Person | Date |
/s/ Seth Boro, Managing Partner of Thoma Bravo Partners XI, L.P. | | 8/5/2020 |
**Signature of Reporting Person | Date |
/s/ Seth Boro, Managing Partner of Thoma Bravo Partners X, L.P., the general partner of Thoma Bravo Fund X, L.P. | | 8/5/2020 |
**Signature of Reporting Person | Date |
/s/ Seth Boro, Managing Partner of Thoma Bravo Partners X, L.P., the general partner of Thoma Bravo Fund X-A, L.P. | | 8/5/2020 |
**Signature of Reporting Person | Date |
/s/ Seth Boro, Managing Partner of Thoma Bravo Partners X, L.P., the general partner of Thoma Bravo Special Opportunities Fund I, L.P. | | 8/5/2020 |
**Signature of Reporting Person | Date |
/s/ Seth Boro, Managing Partner of Thoma Bravo Partners X, L.P., the general partner of Thoma Bravo Special Opportunities Fund I AIV, L.P. | | 8/5/2020 |
**Signature of Reporting Person | Date |
/s/ Seth Boro, Managing Partner of Thoma Bravo Partners XI, L.P., the general partner of Thoma Bravo Fund XI, L.P. | | 8/5/2020 |
**Signature of Reporting Person | Date |
/s/ Seth Boro, Managing Partner of Thoma Bravo Partners XI, L.P., the general partner of Thoma Bravo Fund XI-A, L.P. | | 8/5/2020 |
**Signature of Reporting Person | Date |
/s/ Seth Boro, Managing Partner of Thoma Bravo Partners XI, L.P., the general partner of Thoma Bravo Executive Fund XI, L.P. | | 8/5/2020 |
**Signature of Reporting Person | Date |
Dynatrace (NYSE:DT)
Historical Stock Chart
From Jun 2024 to Jul 2024
Dynatrace (NYSE:DT)
Historical Stock Chart
From Jul 2023 to Jul 2024